From Rhythm Pharma Gets $21M A Round to Target Obesity, Diabetes:

Rhythm Pharmaceuticals
Rhythm Pharmaceuticals

Rhythm Pharmaceuticals develops drugs for diabetes, obesity, and other metabolic conditions.